BEINHEIM, FRANCE

Catalent’s Beinheim, France facility is our European Center of Excellence for development and manufacturing of Lipid-based Drug Delivery Systems including flagship RP Scherer Softgels. The facility houses softgel development and commercial manufacturing operations with capacity of 2.5 billion softgel capsules per year. In addition to hormones, controlled substances, cytostatics and highly potent drugs, the site specializes in accelerated development pathways to get to clinic as quickly as 16 weeks! Our broad expertise in OEB 1-4, Hormones, Cytostatics and DEA I-V plus C-Class Type Suite for Ophthalmic with state-of-art 1664 ft2 Dedicated Lab for High Potent Drugs can handle even your most challenging products.

Size: 92,000 ft2

CAPABILITIES:

• Formulation Development and Manufacturing services for:
  • Controlled Substances
  • Highly Potent Compounds
  • Hormones
• Rx and OTC Softgel development and manufacturing
• Pediatric softgel and oral formulations development

FEATURED TECHNOLOGIES:

• OptiForm® Solution Suite
• OptiGel™ Bio Technology
• RP Scherer Softgel Technology
• Optigel DR

ACCREDITATIONS

• EMA Approved
• FDA Approved
• ANSM
• ANVISA
• CFDA (China)
• MOH (Saudi Arabia)

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

CAREERS

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume.

GENDER EQUALITY

Catalent Beinheim is committed to gender equality, the site scored 93/100 on equity of treatment between men and women index, according to French laws.

Conformément au décret n° 2019-15 du 8 janvier 2019 l’index égalité professionnel est, pour le site de Beinheim (67) : 93